The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
|
|---|---|
| Published in |
Frontiers in Pharmacology, February 2023
|
| DOI | 10.3389/fphar.2023.1120911 |
| Pubmed ID | |
| Authors |
Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, Antonello Mai |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Sweden | 1 | 33% |
| United Kingdom | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 40 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 15% |
| Other | 1 | 3% |
| Student > Bachelor | 1 | 3% |
| Student > Doctoral Student | 1 | 3% |
| Student > Ph. D. Student | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 29 | 73% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 3 | 8% |
| Biochemistry, Genetics and Molecular Biology | 3 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Arts and Humanities | 1 | 3% |
| Veterinary Science and Veterinary Medicine | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 28 | 70% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2023.
All research outputs
#6,830,213
of 23,880,375 outputs
Outputs from Frontiers in Pharmacology
#2,962
of 17,738 outputs
Outputs of similar age
#123,376
of 429,117 outputs
Outputs of similar age from Frontiers in Pharmacology
#76
of 893 outputs
Altmetric has tracked 23,880,375 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 17,738 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,117 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 893 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.